Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2007
12/12/2007EP1864976A1 Propane-1,3-dion derivative or salt thereof
12/12/2007EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007EP1863770A2 Ring closing and related methods and intermediates
12/12/2007EP1752452A9 Propane-1,3-dione derivative or its salt
12/12/2007CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/11/2007US7307170 Epindolidione pigments
12/11/2007US7307084 Gastric secretion inhibiting and excellent gastric and intestinal protective action properties, gastrointestinal disorder
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007091276A3 Novel crystal form of omeprazol sodium
12/05/2007EP1861387A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same
12/05/2007EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands
12/05/2007EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists
12/05/2007CN101083986A Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (scd)
12/05/2007CN100352816C Nociceptin analogs
12/04/2007US7304086 Inhibitors of glutaminyl cyclase
12/04/2007US7304085 Nitrogen-containing heteroaryl derivatives
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304067 (S)-2-[(R)-5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007WO2006106326A8 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/29/2007US20070275995 Thiobenzimidazole derivatives
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/27/2007US7301036 Methyl 4-[(3-methyl-4-methylsufonyl-2-{[4-(trifluoromethoxy)-phenyl]imino}-6-(trifluoromethyl)-2,3-dihydro-1H-benzimidazol-1-yl)methyl]benzoate; glucagon receptor antagonists; type 2 diabetes mellitus
11/27/2007US7301035 Intermediates for the synthesis of irbesartan
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300928 Benzimidazolidinone derivatives as muscarinic agents
11/27/2007US7300917 Remedy for chronic disease
11/22/2007WO2007134169A2 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
11/22/2007WO2007131955A1 Porous metal organic framework based on pyrroles and pyridinones
11/22/2007WO2006049835A3 Indole and benzimidazole derivatives
11/22/2007US20070270478 e.g. 3-[4-(3,5-bis-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2,3-difluoro-phenyl)-acrylonitrile; immunosuppressant; bioavailability; side effect reduction; interleukin-2 inhibitor
11/22/2007US20070270476 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/22/2007US20070270437 Such as 5-{6-[(Methylsulfonyl)methyl]-1H-benzimidazol-1-yl}-3-({(1R)-1-[2-(trifluoromethyl)phenyl]-ethyl}oxy)-2-thiophenecarboxamide; for conditions associated with polo-like kinases
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070269368 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; low molecular weight compounds; non-immunogenic
11/22/2007US20070267970 Nitrogen-containing heterocyclic derivatives and organic electroluminescence device using the same
11/22/2007CA2650609A1 Porous metal organic framework based on pyrroles and pyridinones
11/21/2007EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
11/21/2007EP1856069A1 Process for the preparation of substituted benzoxazole compounds
11/21/2007CN101076531A Carboxylic acid peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101074213A Synthesis of 2-n-propyl-4-methyl-6(1-methylbenzimidazole-2-radicle) benzimidazole and its use in synthesis of timishatan and its salts
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349874C Novel compounds
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007CA2429642C Fused heteroaromatic glucokinase activators
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007WO2007130780A2 Benzimidazole modulators of vr1
11/15/2007WO2007128492A1 Novel pharmaceutical compositions
11/15/2007WO2007128086A2 Novel viral replication inhibitor
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265324 Such as veliparib and temozolomide; poly/adp-ribose/polymerase (PARP)
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265258 Quinazoline derivatives as phosphodiesterase 10 inhibitors
11/15/2007US20070265250 Imidazole compounds
11/15/2007CA2651128A1 Benzimidazole modulators of vr1
11/15/2007CA2649882A1 Novel pharmaceutical compositions
11/14/2007EP1853610A1 N-phenyl benzamide derivatives as sirtuin modulators
11/14/2007EP1853591A1 Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP0998461B1 Process for the preparation of imidazolones
11/14/2007CN100348595C Simulated moving bed chromatography separating method of omeprazole antimer
11/13/2007US7294721 Alkylating the free amino group of (R)-2-(4-cyanophenylaminomethyl)-1-methyl-5-[1-amino-1-(pyrrolidinocarbonyl)-ethyl]-benzimidazole with an alkyl haloacetate, changing the cyano to an amidine, precipitating the p-toluenesulfonic acid salt, hydrolyzing the ester, and precipitating the HCl salt
11/13/2007US7294643 UK-1 analogues: methods of preparation and use
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007US20070259932 Benzimidazole derivatives, their production and use
11/08/2007US20070259873 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
11/08/2007CA2665818A1 Therapeutic compounds
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2648139A1 Diaryl thiohydantoin compounds and their use in the treatment of hyperproliferative disorders
11/07/2007EP1851203A2 Inhibitors of checkpoint kinases
11/07/2007EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007CN101068807A Method for production of candesartan
11/07/2007CN101068792A Amorphous and polymorphic forms of telmisartan sodium
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291615 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/06/2007US7291611 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain
11/06/2007CA2353527C Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007122341A2 Specific monocationic monochromophoric hydrazone compounds containing a 2-(benz)imidazolium unit, their synthesis, dyeing compositions comprising them, method of dyeing keratin fibres
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007121578A1 Indole amide derivatives as ep4 receptor antagonists
11/01/2007WO2007047351A3 Methods for treating hypertension in overweight and obese individuals
11/01/2007WO2007047146A3 Inhibitors of viral replication
11/01/2007US20070254934 Antiviral drugs for treatment of arenavirus infection
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2648729A1 Indole amide derivatives as ep4 receptor antagonists
10/2007
10/31/2007EP1848705A2 Exo- and diastereo- selective syntheses of himbacine analogs
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 154